<scp>Global coronavirus pandemic</scp>
            (
            <scp>SARS‐CoV</scp>
            ‐2):
            <scp>Past</scp>
            ,
            <scp>present</scp>
            ,
            <scp>and future of pediatric dermatology</scp>

Simonetti, Oriana; Diotallevi, Federico; Campanati, Anna; Brisigotti, Valerio; Radi, Giulia; Molinelli, Elisa; Bobyr, Ivan; Martina, Emanuela; Paolinelli, Matteo; Sapigni, Claudia; Offidani, Annamaria

doi:10.1111/dth.13767

Cited by 3 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In conclusion, despite the encouraging experience of our centre and other centres around the world, the relative weight of hydroxychloroquine in the treatment or prevention of COVID‐19 disease, either alone or in association with macrolides, has not be established yet 22,23 . Recent studies also highlight the misleading nature of anecdotal experiences reported when contrasted with the controlled clinical trials.…”

Section: Variables N = 50mentioning

confidence: 87%

Hydroxychloroquine, dermatology, and SARS‐CoV‐2: Updating an old association

Diotallevi

Campanati

Radi

et al. 2020

Journal of Medical Virology

Self Cite

View full text Add to dashboard Cite

Section: Variables N = 50mentioning

confidence: 87%

Hydroxychloroquine, dermatology, and SARS‐CoV‐2: Updating an old association

Diotallevi

Campanati

Radi

et al. 2020

Journal of Medical Virology

Self Cite

View full text Add to dashboard Cite

Global coronavirus pandemic ( SARS‐CoV ‐2): Past , present , and future of pediatric dermatology

Simonetti

Diotallevi

Campanati

et al. 2020

Dermatologic Therapy

Self Cite

View full text Add to dashboard Cite

Two months have passed since the World Health Organization (WHO) declared the pandemic of the Coronavirus Disease 19 (COVID-19), caused by the SARS-CoV-2 virus, on 11 March 2020. Medical and healthcare workers have continued to be on the frontline to defeat this disease, however, continual changes are being made to their working habits which are proving to be difficult. Although the skin is not the main target of the SARS-CoV-2 infection, it is strongly involved both directly and indirectly, in many aspects of dermatological disease management, and particularly in

show abstract

Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know

Diotallevi

Simonetti

Radi

et al. 2021

Acta Dermatovenerologica Alpina Pannonica Et Adriatica

Self Cite

View full text Add to dashboard Cite

Almost 13 months have passed since the World Health Organization (WHO) declared the coronavirus disease 19 (COVID-19) pandemic, caused by the SARS-CoV-2, on March 11th, 2020. During this period, we have realized that the most effective weapon we have to prevent SARS-CoV-2 infection, or to make it less aggressive, is vaccines. Currently, according to the WHO document "Draft landscape of COVID-19 candidate vaccines," there are 275 vaccines in development against the virus, although at the moment there are four preparations in distribution in the United States and in Europe. The characteristics of these vaccines are quite different from each other and may even be unfamiliar in the medical field. In particular, among dermatologists, knowledge of vaccines is of fundamental importance, especially in atopic dermatitis. Atopic patients are aware of having a predisposition to develop allergies, and so they are asking dermatologists about the safety of the vaccines currently available against the SARS-CoV-2. This article provides an up-to-date overview of this topic by reviewing current literature and sharing our personal experience.

show abstract

Global coronavirus pandemic ( SARS‐CoV ‐2): Past , present , and future of pediatric dermatology

Cited by 3 publications

References 10 publications

Hydroxychloroquine, dermatology, and SARS‐CoV‐2: Updating an old association

Hydroxychloroquine, dermatology, and SARS‐CoV‐2: Updating an old association

Global coronavirus pandemic ( SARS‐CoV ‐2): Past , present , and future of pediatric dermatology

Vaccines for COVID-19 in patients with atopic dermatitis: three things every dermatologist should know

Contact Info

Product

Resources

About